120 related articles for article (PubMed ID: 23178801)
21. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584
[TBL] [Abstract][Full Text] [Related]
22. Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism.
Liebenberg N; Wegener G; Harvey BH; Brink CB
Behav Brain Res; 2010 May; 209(1):137-41. PubMed ID: 20117144
[TBL] [Abstract][Full Text] [Related]
23. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
24. Metallothionein I and II mitigate age-dependent secondary brain injury.
Natale JE; Knight JB; Cheng Y; Rome JE; Gallo V
J Neurosci Res; 2004 Nov; 78(3):303-14. PubMed ID: 15389833
[TBL] [Abstract][Full Text] [Related]
25. Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone.
Wang L; Gang Zhang Z; Lan Zhang R; Chopp M
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1150-8. PubMed ID: 15815584
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
[TBL] [Abstract][Full Text] [Related]
27. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
29. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
30. Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects.
Foresta C; Caretta N; Zuccarello D; Poletti A; Biagioli A; Caretti L; Galan A
Eye (Lond); 2008 Jan; 22(1):144-9. PubMed ID: 17585311
[TBL] [Abstract][Full Text] [Related]
31. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
32. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
[TBL] [Abstract][Full Text] [Related]
33. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of 3'5'-cyclic guanosine monophosphate-specific phosphodiesterase in the porcine cumulus-oocyte complex affects steroidogenesis during in vitro maturation.
Sasseville M; Côté N; Gagnon MC; Richard FJ
Endocrinology; 2008 Nov; 149(11):5568-76. PubMed ID: 18669600
[TBL] [Abstract][Full Text] [Related]
35. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
De Young L; Yu D; Freeman D; Brock GB
Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
[TBL] [Abstract][Full Text] [Related]
36. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
37. Basal metallothionein-I/II protects against NMDA-mediated oxidative injury in cortical neuron/astrocyte cultures.
Yu X; Guo J; Fang H; Peng S
Toxicology; 2011 Mar; 282(1-2):16-22. PubMed ID: 21215786
[TBL] [Abstract][Full Text] [Related]
38. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice.
Al Qadi-Nassar B; Bichon-Laurent F; Portet K; Tramini P; Arnoux B; Michel A
Fundam Clin Pharmacol; 2007 Dec; 21(6):611-20. PubMed ID: 18034662
[TBL] [Abstract][Full Text] [Related]
39. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
Ferrini MG; Kovanecz I; Sanchez S; Vernet D; Davila HH; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
[TBL] [Abstract][Full Text] [Related]
40. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
Giordano D; De Stefano ME; Citro G; Modica A; Giorgi M
Biochim Biophys Acta; 2001 May; 1539(1-2):16-27. PubMed ID: 11389965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
